Share Email Print
cover

Proceedings Paper

Photodynamic therapy with photofrin II derivative in the treatment of carcinosarcoma of rats with diabetes mellitus
Author(s): Vasile F. Dima; Virgil V. Vasiliu; Mircea D. Ionescu; Dezideriu Laky
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

Four batches of Wistar rats with Walker-256 carcinosarcoma were used to test the effects of PDT upon `in vivo' tumor growth. Ten days after tumor transplantation, rats from batch I(DM) were exposed to Photofrin II (20 mg/kg), given i.p. 24 h before exposure to laser (632.8 nm; 10 mw; He-Ne laser), five doses given at 4 days intervals; batch II and batch III received sole treatment (DM or PDT). The control batch IV included animals with untreated Walker-256 tumors. The animals were followed up 42 days.

Paper Details

Date Published: 8 March 1995
PDF: 3 pages
Proc. SPIE 2461, ROMOPTO '94: Fourth Conference in Optics, (8 March 1995); doi: 10.1117/12.203586
Show Author Affiliations
Vasile F. Dima, Cantacuzino Institute (Romania)
Virgil V. Vasiliu, Institute of Atomic Physics (Romania)
Mircea D. Ionescu, Cantacuzino Institute (Romania)
Dezideriu Laky, Victor Babes Institute (Romania)


Published in SPIE Proceedings Vol. 2461:
ROMOPTO '94: Fourth Conference in Optics

© SPIE. Terms of Use
Back to Top